Literature DB >> 28202265

Association between chronic exposure to air pollution and mortality in the acute respiratory distress syndrome.

Barret Rush1, Robert C McDermid2, Leo Anthony Celi3, Keith R Walley4, James A Russell5, John H Boyd6.   

Abstract

The impact of chronic exposure to air pollution and outcomes in the acute respiratory distress syndrome (ARDS) is unknown. The Nationwide Inpatient Sample (NIS) from 2011 was utilized for this analysis. The NIS is a national database that captures 20% of all US in-patient hospitalizations from 47 states. Patients with ARDS who underwent mechanical ventilation from the highest 15 ozone pollution cities were compared with the rest of the country. Secondary analyses assessed outcomes of ARDS patients for ozone pollution and particulate matter pollution on a continuous scale by county of residence. A total of 8,023,590 hospital admissions from the 2011 NIS sample were analyzed. There were 93,950 patients who underwent mechanical ventilation for ARDS included in the study. Patients treated in high ozone regions had significantly higher unadjusted hospital mortality (34.9% versus 30.8%, p < 0.01) than patients in cities with control levels of ozone. After controlling for all variables in the model, treatment in a hospital located in a high ozone pollution area was associated with an increased odds of in-hospital mortality (OR 1.11, 95% CI 1.08-1.15, p < 0.01). After adjustment for all variables in the model, for each increase in ozone exposure by 0.01 ppm the OR for death was 1.07 (95% CI 1.06-1.08, p < 0.01). Similarly, for each increase in particulate matter exposure by 10 μg/m3, the OR for death was 1.08 (95% CI 1.02-1.16, p < 0.01). Chronic exposure to both ozone and particulate matter pollution is associated with higher rates of mortality in ARDS. These preliminary findings need to be confirmed by further detailed studies.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28202265      PMCID: PMC5683074          DOI: 10.1016/j.envpol.2017.02.014

Source DB:  PubMed          Journal:  Environ Pollut        ISSN: 0269-7491            Impact factor:   8.071


  28 in total

1.  The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation.

Authors:  Jesús Villar; Jesús Blanco; José Manuel Añón; Antonio Santos-Bouza; Lluís Blanch; Alfonso Ambrós; Francisco Gandía; Demetrio Carriedo; Fernando Mosteiro; Santiago Basaldúa; Rosa Lidia Fernández; Robert M Kacmarek
Journal:  Intensive Care Med       Date:  2011-10-14       Impact factor: 17.440

2.  Cigarette smoking, alcohol consumption, and risk of ARDS: a 15-year cohort study in a managed care setting.

Authors:  C Iribarren; D R Jacobs; S Sidney; M D Gross; M D Eisner
Journal:  Chest       Date:  2000-01       Impact factor: 9.410

3.  Ozone-induced inflammation in the lower airways of human subjects.

Authors:  H S Koren; R B Devlin; D E Graham; R Mann; M P McGee; D H Horstman; W J Kozumbo; S Becker; D E House; W F McDonnell
Journal:  Am Rev Respir Dis       Date:  1989-02

4.  Long-Term Ozone Exposure Increases the Risk of Developing the Acute Respiratory Distress Syndrome.

Authors:  Lorraine B Ware; Zhiguo Zhao; Tatsuki Koyama; Addison K May; Michael A Matthay; Fred W Lurmann; John R Balmes; Carolyn S Calfee
Journal:  Am J Respir Crit Care Med       Date:  2016-05-15       Impact factor: 21.405

5.  Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial.

Authors:  V M Ranieri; P M Suter; C Tortorella; R De Tullio; J M Dayer; A Brienza; F Bruno; A S Slutsky
Journal:  JAMA       Date:  1999-07-07       Impact factor: 56.272

6.  Cigarette Smoke Exposure and the Acute Respiratory Distress Syndrome.

Authors:  Carolyn S Calfee; Michael A Matthay; Kirsten N Kangelaris; Edward D Siew; David R Janz; Gordon R Bernard; Addison K May; Peyton Jacob; Christopher Havel; Neal L Benowitz; Lorraine B Ware
Journal:  Crit Care Med       Date:  2015-09       Impact factor: 7.598

7.  Mechanical ventilation with high tidal volume induces inflammation in patients without lung disease.

Authors:  Roselaine Pinheiro de Oliveira; Marcio Pereira Hetzel; Mauro dos Anjos Silva; Daniele Dallegrave; Gilberto Friedman
Journal:  Crit Care       Date:  2010-03-18       Impact factor: 9.097

8.  The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material.

Authors:  Niall D Ferguson; Eddy Fan; Luigi Camporota; Massimo Antonelli; Antonio Anzueto; Richard Beale; Laurent Brochard; Roy Brower; Andrés Esteban; Luciano Gattinoni; Andrew Rhodes; Arthur S Slutsky; Jean-Louis Vincent; Gordon D Rubenfeld; B Taylor Thompson; V Marco Ranieri
Journal:  Intensive Care Med       Date:  2012-08-25       Impact factor: 17.440

9.  The prevalence and impact of mortality of the acute respiratory distress syndrome on admissions of patients with ischemic stroke in the United States.

Authors:  Fred Rincon; Mitchell Maltenfort; Saugat Dey; Sayantani Ghosh; Matthew Vibbert; Jaqueline Urtecho; Jack Jallo; John K Ratliff; John William McBride; Rodney Bell
Journal:  J Intensive Care Med       Date:  2013-06-06       Impact factor: 3.510

10.  Associations between three specific a-cellular measures of the oxidative potential of particulate matter and markers of acute airway and nasal inflammation in healthy volunteers.

Authors:  Nicole A H Janssen; Maciej Strak; Aileen Yang; Bryan Hellack; Frank J Kelly; Thomas A J Kuhlbusch; Roy M Harrison; Bert Brunekreef; Flemming R Cassee; Maaike Steenhof; Gerard Hoek
Journal:  Occup Environ Med       Date:  2014-08-07       Impact factor: 4.402

View more
  8 in total

1.  Impact of Long-Term Exposures to Ambient PM2.5 and Ozone on ARDS Risk for Older Adults in the United States.

Authors:  Jongeun Rhee; Francesca Dominici; Antonella Zanobetti; Joel Schwartz; Yun Wang; Qian Di; John Balmes; David C Christiani
Journal:  Chest       Date:  2019-03-26       Impact factor: 9.410

2.  Low to Moderate Air Pollutant Exposure and Acute Respiratory Distress Syndrome after Severe Trauma.

Authors:  John P Reilly; Zhiguo Zhao; Michael G S Shashaty; Tatsuki Koyama; Jason D Christie; Paul N Lanken; Chunxue Wang; John R Balmes; Michael A Matthay; Carolyn S Calfee; Lorraine B Ware
Journal:  Am J Respir Crit Care Med       Date:  2019-01-01       Impact factor: 21.405

Review 3.  Environmental Factors.

Authors:  Katherine D Wick; Michael A Matthay
Journal:  Crit Care Clin       Date:  2021-10       Impact factor: 3.879

Review 4.  Protective influence of healthful nutrition on mechanisms of environmental pollutant toxicity and disease risks.

Authors:  Jessie B Hoffman; Bernhard Hennig
Journal:  Ann N Y Acad Sci       Date:  2017-06-02       Impact factor: 5.691

5.  Marrow-derived mesenchymal stem cells regulate the inflammatory response and repair alveolar type II epithelial cells in acute lung injury of rats.

Authors:  Qianying Li; Xianyang Chen; Jiujun Li
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

6.  Diesel Exhaust Particulates Enhances Susceptibility of LPS-Induced Acute Lung Injury through Upregulation of the IL-17 Cytokine-Derived TGF-β1/Collagen I Expression and Activation of NLRP3 Inflammasome Signaling in Mice.

Authors:  Dong Im Kim; Mi-Kyung Song; Kyuhong Lee
Journal:  Biomolecules       Date:  2021-01-06

7.  Risk of Acute Respiratory Distress Syndrome Among Older Adults Living Near Construction and Manufacturing Sites.

Authors:  Jongeun Rhee; Francesca Dominici; Antonella Zanobetti; Joel Schwartz; Yun Wang; Qian Di; David C Christiani
Journal:  Epidemiology       Date:  2020-07       Impact factor: 4.860

8.  Pre-admission air pollution exposure prolongs the duration of ventilation in intensive care patients.

Authors:  Annick De Weerdt; Bram G Janssen; Bianca Cox; Esmée M Bijnens; Charlotte Vanpoucke; Wouter Lefebvre; Omar El Salawi; Margot Jans; Walter Verbrugghe; Tim S Nawrot; Philippe G Jorens
Journal:  Intensive Care Med       Date:  2020-03-17       Impact factor: 17.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.